Role of Nonpharmacologic Approach to Fracture and Osteoporosis
Author:
Prince Richard L.
Publisher
Current Medicine Group
Reference15 articles.
1. Watts NB: Bisphosphonate treatment for osteoporosis. In The Osteoporotic Syndrome. Edited by Avioli LV. San Diego: Academic Press, 2000:121–132.
2. Rogers MJ, Gordon S, Benford HL, et al.: Cellular and molecular mechanisms of action of bisphosphonates [review]. Cancer 2000, 88 (12 suppl):2961–2978.
3. Tucci JR, Tonino RP, Emkey RD, et al.: Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 1996, 101:488–501.
4. Harris ST, Watts NB, Genant HK, et al.: Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis—a randomized controlled trial. JAMA 1999, 282:1344–1352.
5. Hosking D, Chilvers CED, Christiansen C, et al.: Prevention of bone loss with alendronate in postmenopausal women under 60 years of age: Early Postmenopausal Intervention Cohort Study Group. N Engl J Med 1998, 338:485–492.